UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (date of earliest event reported): August 6, 2003
UROLOGIX, INC.
--------------
(Exact name of Registrant as specified in its charter)
Minnesota 0-28414 41-1697237
--------- ------- ----------
(State or other jurisdiction of (Commission File Number) (I.R.S. Employer
incorporation) Identification No.)
14405 21st Avenue North
Minneapolis, MN 55447
- ----------------------- -----
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code (763) 475-1400
Items 1-6 and 8-11 are not applicable and therefore omitted.
ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS.
(c) Exhibits
The following is furnished as an exhibit to this Current Report:
Exhibit No. Description of Exhibit
- ----------- ----------------------
99.1 Press release issued August 6, 2003.
ITEM 12. DISCLOSURE OF RESULTS OF OPERATIONS
AND FINANCIAL CONDITION.
On August 6, 2003, Urologix, Inc. issued a press release, furnished as
Exhibit 99.1 to this Form 8-K, disclosing material non-public information
regarding its results of operations for the quarter and fiscal year ended June
30, 2003.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.
UROLOGIX, INC.
By /s/ Fred B. Parks
------------------------------------
Fred B. Parks
Chief Executive Officer
Dated: August 6, 2003